BCA
AMED

Berman Capital Advisors’s Amedisys AMED Stock Holding History

Berman Capital Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1K Buy
13
+6
+86% +$1.25K ﹤0.01% 1792
2021
Q2 		$1K Sell
7
-6
-46% -$1.57K ﹤0.01% 1685
2021
Q1 		$3K Buy
13
+6
+86% +$1.69K ﹤0.01% 1386
2020
Q4 		$2K Hold
7
– – ﹤0.01% 1363
2020
Q3 		$1K Hold
7
– – ﹤0.01% 1395
2020
Q2 		$1K Buy
+7
New +$1.31K ﹤0.01% 1368

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Berman Capital Advisors's AMED Position: Q3 2021 in Review

Berman Capital Advisors increased its Amedisys (AMED) stake by 86% in Q3 2021, buying an estimated $1.25K and bringing the position to 13 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1792.

Berman Capital Advisors first reported a position in AMED in Q2 2020 and has held it in 6 quarters since. The position peaked at $3K in Q1 2021. 352 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Berman Capital Advisors held 13 shares of Amedisys worth $1K as of Q3 2021.
  • Berman Capital Advisors bought 6 Amedisys shares in Q3 2021, an estimated $1.25K.
  • Amedisys made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1792 holding.
  • Berman Capital Advisors first reported a position in Amedisys in Q2 2020 and has held it in 6 quarters since.
  • Berman Capital Advisors's Amedisys position peaked at $3K in Q1 2021.
  • 352 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.